Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.92 USD | +0.89% | +11.31% | -9.87% |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
05-07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- MarketScreener Editorial Features